- Home
- / Hainan Huluwa Pharmaceutical Group
Hainan Huluwa Pharmaceutical Group
Stock Price
¥13.8
2024-10-29
Market Capitalization
¥5.2 B
2024-10-29
Revenue
¥1.4 B
FY, 2024
Hainan Huluwa Pharmaceutical Group Summary
Company Summary
- Overview
- Hainan Huluwa Pharmaceutical Group (海南葫芦娃药业集团股份有限公司) is a company that develops, produces, and sells drugs. It offers pediatric lung heat cough granules and capsules.
- Type
- Public
- Status
- Active
- Founded
- 2008
- Website
- http://www.huluwayaoye.com
- Cybersecurity rating
Table of Contents
Hainan Huluwa Pharmaceutical Group Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥145.2M
- Gross profit (Q1, 2026)
- ¥35.8M
- Net income (Q1, 2026)
- (¥28.4M)
- Cash (Q1, 2026)
- ¥76.6M
- EBIT (Q1, 2026)
- (¥18.4M)
- Enterprise value
- $6.3B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026